Observational studyPloS one2025
Non-menstrual pelvic symptoms and women's quality of life: a cross-sectional observational study.
Observational study in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Deep Dyspareunia One Year After Nerve-Sparing Endometriosis Surgery: An Observational Study Highlighting Undesirable Outcomes.Journal of personalized medicine · 2026Article
- Safety and Reproductive Outcomes of Minimally Invasive Nerve-Sparing Surgery for Deep Endometriosis in Infertile Women: A One-Year Follow-Up Study.Journal of personalized medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEndometriosis-related pain duration and burden are associated with poorer psychological well-being and health-related quality of life (HQoLife). This study aimed to compare the relative burdens of 4 different non-menstrual pelvic symptoms on HQoLife: Deep dyspareunia (DDyspareunia), non-menstrual pelvic pain (NMPelvicPain), non-menstrual dyschezia (NMDyschezia) and non-menstrual dysuria (NMDysuria). SUBJECTS AND
methodsThis is a pre-planned cross-sectional interdisciplinary retrospective observational study. The sample consists of 369 consecutive patients referred for minimally invasive surgery at a private institution. DDyspareunia, NMPelvicPain, NMDyschezia and NMDysuria were assessed with a self-reported 11-point (0-10) numeric rating scale (NRS). The Short Form 36 (SF36) and Endometriosis Health Profile 30 (EHP30) full questionnaires were applied to assess HQoLife. Multiple linear regression models were used to compare the 4 explanatory variables (correlates), which were tested for 19 different HQoLife domains.
resultsMultivariate exploratory analyses indicated that NMPelvicPain and NMDyschezia may be the non-menstrual pelvic symptoms that most impact the HQoLife of women with endometriosis, an association that was observed in practically all domains of both the SF36 and the EHP30 questionnaires. DDyspareunia was the most important symptom for the sexual intercourse EHP30 domain. Despite the biological plausibility and statistical significance found in virtually all models, their low explanatory power suggests the existence of additional major covariates (not contemplated in this study). Moreover, the presence of significant positive intercepts (P<0.001) implies that some HQoLife impairment is expected for any hypothetical woman with endometriosis, even if all 4 correlates' scores are equal to zero. Our findings support the hypothesis that the importance of bowel symptoms has been underestimated in endometriosis assessment whereas the burden of other potential covariates should not be neglected.
conclusionDDyspareunia was the most important non-menstrual pelvic symptoms for the EHP30Sex domain, but NMPelvic Pain and NMDyschezia were the most important for overall HQoLife.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.